USE OF BOSWELLIC ACIDS FOR THE PROPHYLAXIS AND/OR TREATMENT OF DAMAGE TO AND/OR INFLAMMATION OF THE ISLETS OF LANGERHANS

Disclosed are methods and compositions related to the use of boswellic acids (such as acetyl-11-keto- -boswellic acid, 11-keto- -boswellic acid, -boswellic acid, acetyl- -boswellic acid, 9,11-dehydro- -boswellic acid, acetyl-9,11-dehydro- -boswellic acid, α-boswellic acid, acetyl-α-boswellic acid, 1...

Full description

Saved in:
Bibliographic Details
Main Author AMMON HERMANN P.T
Format Patent
LanguageEnglish
Published 22.03.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed are methods and compositions related to the use of boswellic acids (such as acetyl-11-keto- -boswellic acid, 11-keto- -boswellic acid, -boswellic acid, acetyl- -boswellic acid, 9,11-dehydro- -boswellic acid, acetyl-9,11-dehydro- -boswellic acid, α-boswellic acid, acetyl-α-boswellic acid, 11-dehydro-α-boswellic acid, acetyl-9,11-dehydro-α-boswellic acid, lupeolic acid, acetyl lupeolic acid, 12-ursene-2-diketone, incensole, incensole acetate, a derivative, in particular an ester thereof, a pharmaceutically acceptable salt thereof, a combination thereof, or a preparation containing one or more of these compounds) for the human medical or veterinary prophylaxis and/or treatment of: a) damage to and/or inflammation of the islets of Langerhans and/or b) damage to the B-cells of the islets of Langerhans.
Bibliography:Application Number: US201113240972